Professor Dan Peer of Tel Aviv University (see here previously) has extended the effectiveness of his nanoparticle therapies. He has taken the RNA technology used in coronavirus vaccines to target only the specific T-cells and genes responsible for inflammatory diseases.
GPS therapy for inflammatory diseases
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.